Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical ...

At ESMO 2025, Eli Lilly’s Verzenio and Novartis’ Kisqali both demonstrated durable efficacy in hormone receptor-positive, ...

In this week’s Applied Clinical Trials Brief, we highlight key findings from the 2025 State of the Industry Survey, explore how AI is transforming trial efficiency and patient engagement, and examine ...

Gain insight into why early toxicology readiness and strong scientific collaboration with CRO partners are critical to ...

See how early patient inclusion, integrated regulatory planning, and seamless CRO partnerships can help biotechs accelerate ...

Understand how adaptive human-in-the-loop frameworks can maintain safety and decision quality as AI becomes more embedded in ...

This is the Applied Clinical Trials Brief —your fast track to the latest insights in clinical research operations. In under ...

Designing adhesion and durability for biopharmaceuticals in the most extreme cold chain environments.

Learn how streamlined confidentiality agreements and consistent workflows can speed site activation and improve sponsor-site ...

Gain perspective on how agentic AI can bridge eCOA, EDC, IRT, and CTMS platforms to reduce manual effort and improve ...

Take a closer look at how agentic AI can automate repetitive monitoring tasks while keeping human oversight central to ...

Eli Lilly’s oral GLP-1 therapy, orforglipron, met all primary and key secondary endpoints in the Phase III ACHIEVE-2 and ACHIEVE-5 studies, showing significant A1C reduction, weight loss, and ...